Pakistan has launched a nationwide campaign to administer a single-dose HPV vaccine to 13 million girls aged 9 to 14, marking a major step in the country’s fight against cervical cancer.
At a workshop aimed at raising awareness, health experts, government officials, and development partners stressed the role of hospitals, doctors, and civil society in ensuring the campaign’s success.
Dr. Farhaj Uddin, Program Manager for the HPV Vaccination Campaign, reaffirmed his commitment to supporting national efforts through advocacy, communication, and community mobilization to dispel misconceptions and improve vaccine access.
Dr. Khurram Shahzad highlighted that doctors’ voices play a vital role in countering myths and building public trust. DG Health Services CDA, Dr. Irshad Ali Jokhio, confirmed that the HPV vaccine will be added to Pakistan’s basic immunization program.
Representing WHO, Dr. Rozeena Khalid noted that cervical cancer is the second most common cancer among women in Pakistan, with a mortality rate higher than breast cancer. She emphasized the importance of vaccinating adolescent girls to reduce future cases. Dr. Saima Khursheed Zubair added that while cervical cancer affects adult women, prevention must start by vaccinating girls under 15.
Speakers revealed that Pakistan aims to vaccinate 18 million girls over the next three years, a goal achievable only with strong participation from civil society and healthcare providers.
With this campaign, Pakistan becomes the 150th country to introduce the HPV vaccine, a milestone hailed by health leaders as a historic initiative to protect adolescent girls, prevent cervical cancer, and build a healthier future for communities.
